Scottish Parliament CPG on Life Sciences – November 2024
On 19th November 2024, Microbira’s CEO, Marianne Ismail, attended the Cross-Party Group (CPG) on Life Sciences meeting. This prestigious event, held at the Scottish Parliament, was convened by Kenneth Gibson MSP to unite life sciences leaders. Importantly, the meeting provided a platform to discuss critical advancements and strategies for tackling global health challenges.
Throughout the evening, insightful presentations from renowned experts fostered engaging discussions on key health and environmental issues. For instance, Professor Deborah Williamson presented the Pathogen Genomics Strategy Plan, focusing on infectious disease management and innovative solutions. Additionally, Professor Tim Aitman introduced the One Health Genomics Edinburgh Community, addressing biodiversity loss and antimicrobial resistance. Together, these talks explored advancing pathogen-agnostic public health services to meet urgent global needs.
Of particular relevance to Microbira was the presentation by Dr Poonam Malik and Dr Stuart Hannah. Their research highlighted rapid antibiotic susceptibility testing as a means to improve antimicrobial prescriptions. This innovation closely aligns with Microbira’s mission of advancing cutting-edge diagnostics and sustainable healthcare solutions.
Moreover, Marianne Ismail’s attendance demonstrates Microbira’s commitment to engaging with Scotland’s dynamic life sciences sector. By participating in this important forum, the company underscores its dedication to collaboration and meaningful innovation. These efforts reflect its ongoing contributions to both medical research and public health.
As the life sciences community continues to evolve, such events play a crucial role in fostering knowledge sharing and action. Microbira’s presence at the CPG meeting reinforces its position as a leader in diagnostics and biotechnology. With each engagement, the company further establishes itself as a forward-thinking innovator shaping the future of sustainable healthcare.
By maintaining its focus on collaboration, Microbira remains committed to addressing today’s pressing global health challenges.
Visit our product page for more information on MAAP-IR.
